2-deoxy-2-(18Fluorine)-fluoro-D-glucose (FDG) PET/CT is an integral part of lung carcinoma
staging and frequently used in the assessment of solitary pulmonary nodules. However, a …

There have been several endeavors made to investigate the potential role of 2-deoxy-2-[18
F] fluoro-D-glucose positron emission tomography (FDG-PET)(and tracers) and PET …

Purpose The aim of this work was to non-invasively establish the feasibility of assessing 2-
deoxy-2-[18 F] fluoro-D-glucose (18 F-FDG) lung metabolism with the use of a late dynamic …

Background Respiratory motion can diminish PET image quality and lead to inaccurate
lesion quantifications. Data-driven gating (DDG) was recently introduced as an effective …

Benign and malignant pulmonary lesions usually are differentiated by 18F-FDG PET with a
semiquantitative 18F-FDG standardized uptake value (SUV) of 2.5. However, the frequency …

A data-driven method for respiratory gating in PET has recently been commercially
developed. We sought to compare the performance of the algorithm with an external, device …

Our objective was to compare 18F-FDG PET/MRI (performed using a contrast-enhanced T1-
weighted fat-suppressed volume-interpolated breath-hold examination [VIBE]) with 18F-FDG …

This issue of PET Clinics focuses on Lung Cancer, and is edited by Drs. Gang Cheng and
Timothy Akhurst. Articles will include: FDG PET/CT for lung cancer staging; Lung neoplasms …

2-deoxy-2-[18 F] fluoro-D-glucose [18 F] FDG-PET/CT represents the metabolic imaging of
choice in various cancer types. Used either at diagnosis or during treatment response …

This article discusses the role of PET/CT in contributing to precision medicine in lung cancer,
and provides the perspective of the Society of Nuclear Medicine and Molecular Imaging …